🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thrilled to share our exciting collaborative work with Carolyn Bertozzi, Ron Levy, Steven Artandi, MD, PhD Steve Artandi featured on the cover of CellChemicalBiology, led by the talented Caitlyn Miller and Idit Sagiv-Barfi.

Read Jennifer Cochran's recent CellChemicalBiology article: Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression CochranLab #AACR22 hubs.li/Q017Kf5f0

Join #PEGS22 Plenary Keynote Jennifer Cochran, PhD, today at 4:10pm to discuss challenges and opportunities in developing non-antibody protein therapeutics. pegsummit.com/plenary-keynote

Excited to share this collaborative work published in Cell on an exquisite drug-regulated CAR platform. Led by Louai Labanieh, jointly advised Bioengineering PhD student in the lab of Crystal Mackall

TLR9 (CpG) agonist was chemically conjugated to polyspecific integrin-binding peptide (PIP) that is capable to localise various types of solid tumours as explained by Caitlyn Miller from CochranLab at Stanford University #PEGS22 PEGS Summit

Immensely enjoyed the reviewing experience and spending the day-and-a-half on Stanford University campus with this special group of people Kumar Lab, UC Berkeley Widya Mulyasasmita chuba oyolu Tejal A. Desai and Darelene Soloman of Agilent Technologies. Thank you @StanfordBioE CochranLab for the hospitality!

Congratulations to faculty fellows Lauren O'Connell, Martha Cyert & Jennifer Cochran CochranLab for winning the 2022 @StanfordMedOFDD Faculty Women’s Forum Awards! Learn more: stanford.io/3zt8wQz

Wonderful insights and leadership from Stanford University Stanford Medicine CochranLab Karl Deisseroth Christoph Westphal #Longwoodhealthcareleaders

Congrats to joint @StanfordBioE PhD student Michael Hollander, Carolyn Bertozzi and team for this exciting collaborative work!

Thrilled to announce that our new PIP-CpG paper is now live The Journal of Immunology . PIP-CpG is a tumor-targeting immunotherapy that is in preclinical development & we are hoping to advance it to the clinic in the coming years. doi.org/10.4049/jimmun… . A 🧵👇(1/13)

In the physiologically relevant MMTV-PyMT GEMM model, Caitlyn Miller Idit Sagiv-Barfi Carolyn Bertozzi demonstrated that systemic delivery of a tumor integrin-targeted TLR9 agonist (PIP-CpG) led to sustained elimination [...] bit.ly/3Cu9QTC

#JI_TopRead from Caitlyn Miller CochranLab Carolyn Bertozzi Stanford Health Care | #TLR9 agonist, PIP-CpG, enhances the CD8 #Tcell response to spontaneous tumors | #ReadTheJI #immunology #AuthorChoice #FreetoRead #TumorImmunology 👉 ow.ly/FTbV50P6FNv

I'm excited to share our work "Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and function" that's now out in PNAS! 1/3 Link to paper: pnas.org/doi/10.1073/pn… Link to press release: news.stanford.edu/2024/03/11/pro…

Congratulations to Professor Jennifer Cochran CochranLab who was recently elected to the National Academy of Engineering National Academy of Engineering for protein discovery and development, biotechnology entrepreneurship, and leadership in academic bioengineering! news.stanford.edu/stories/2025/0…

Excited to see our lab's B cell screening technology, spearheaded by Cochran alum and xCella Biosciences co-founder Bob Chen, rolled out as a now commercial instrument from antibody discovery company OmniAb.

Congrats to lab alum Bob Chen and the OmniAb team on winning "Best in Show" at PEGS Summit for their innovative and impactful xPloration B cell/ Ab screening platform.

Proud to have our work with Carolyn Bertozzi and Ron Levy on tumor-targeted cancer therapeutics featured in the Stanford Office of Technology Licensing (OTL) annual report tinyurl.com/pawxhfhx; now being developed at TwoStep Therapeutics, led by lab alum Caitlyn Miller Caitlyn Miller

Check out our review article describing recent updates in LAG3 biology and therapeutics in Trends in Pharmacological Sciences with Jun Wang and Curie.Bio colleagues: authors.elsevier.com/c/1lFgxbg0kscyR